Our Story
Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. We demonstrate that significant companies are best built in close working partnerships with entrepreneurs.
How We Can Help
Our unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates of return for both its entrepreneurs and investors.
Specialization
Small molecule therapeutics
Biologics and vaccines
Drug delivery
Platform technologies
Medical devices